- Additive Antiproteinuric Effect of Combination Therapy with ACE Inhibitor and Angiotensin II Receptor Antagonist: Differential Short-term Response between IgA Nephropathy and Diabetic Nephropathy
-
Kim MJ, Song JH, Suh JH, Lee SW, Kim GA
- KMID: 720876
- Yonsei Med J.
- 2003 Jun;44(3):463-472.
- doi: 10.3349/ymj.2003.44.3.463
In previous studies, the synergistic antiproteinuric effect of the combination therapy of ACE inhibitors and angiotensin II receptor antagonists (ATRAs) has been inconsistent in relation to underlying renal diseases. The... -
- CITED
-
- Close
- SHARE
-
- Close
- Inhibitory Effect of Angiotensin II Receptor Antagonist on the Contraction and Growth of Hepatic Stellate Cells
-
Baik SK, Jo HS, Suk KT, Kim JM, Lee BJ, Choi YJ, Kim HS, Lee DK, Kwon SO, Lee KI, Cha SK, Park KS, Kong ID
- KMID: 772535
- Korean J Gastroenterol.
- 2003 Aug;42(2):134-141.
BACKGROUNDS/AIMS: This study aimed to investigate the effects of angiotensin II (ANG II) and its receptor antagonist (losartan) on the contraction and growth of HSCs. METHODS: HSCs were isolated... -
- CITED
-
- Close
- SHARE
-
- Close
- Aldose Reductase Inhibitor Ameliorates Renal Vascular Endothelial Growth Factor Expression in Streptozotocin-Induced Diabetic Rats
-
Sung JK, Koh JH, Lee MY, Kim BH, Nam SM, Kim JH, Yoo JH, Kim SH, Hong SW, Lee EY, Choi R, Chung CH
- KMID: 1074990
- Yonsei Med J.
- 2010 May;51(3):385-391.
- doi: 10.3349/ymj.2010.51.3.385
PURPOSE: The vascular endothelial growth factor (VEGF) expression of podocyte is one of the well-known major factors in development of diabetic nephropathy. In this study, we investigated the effects of... -
- CITED
-
- Close
- SHARE
-
- Close
